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We showed recently that short-term increases in stratum corneum (SC) pH are accompanied by minor alterations in
permeability barrier homeostasis and SC integrity/cohesion. Since prolonged SC neutralization more closely mir-
rors clinical situations (i.e., neonatal skin, occupational dermatitis conditions), we assessed here whether sus-
tained elevations of SC pH by long-term application of 1,1,3,3-tetramethylguanidine superbase provoke profound
alterations in SC function. Sustained SC neutralization altered not only barrier recovery kinetics but also basal
permeability barrier function. These abnormalities were attributable to a decrease in b-glucocerebrosidase (b-
GlcCer’ase) and acidic sphingomyelinase (aSMase) catalytic activity and enzyme degradation consequent to a pH-
induced sustained serine protease (SP) activity. The role of SP in this process was shown by the normalization of
enzyme activities/content by co-applied SP inhibitors (SPI). To address whether lipid-processing enzymes are
potential substrates for the stratum corneum chymotryptic enzyme (SCCE), protein extracts from human SC were
treated for 2 h at 371C with recombinant active SCCE at pH 7.2. Recombinant SCCE induced a significant decrease
in the immunoblotting of both b-GlcCer’ase or aSMase compared with control experiments performed in the ab-
sence of the active SCCE. Finally, with sustained SC neutralization, SC integrity/cohesion deteriorated, attributable
to SP-mediated degradation of corneodesmosomes (CD) as well as CD constituent proteins, desmoglein 1. These
abnormalities were again reversed by co-applied SPI. In conclusion, prolonged SC neutralization provokes pro-
found abnormalities in SC function, due to pH-induced high SP activity that, in turn, degrades lipid processing
enzymes and CD proteins.
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As the primary interface with a desiccating external milieu,
the primary function of the stratum corneum (SC) is to limit
excess transcutaneous water loss from the organism’s
aqueous interior. Yet, in addition, the SC also protects
against mechanical/desquamatory insults, UV-irradiation,
oxidant injury, and the ingress of xenobiotes (Elias, 1989).
The acidic surface mantle of the skin, first described 76 y
ago, has long been thought to mediate cutaneous antimi-
crobial activity (Korting et al, 1990; Korting and Braun-
Falco, 1996). Recent studies point to other pH-dependent
functions of the SC acid mantle (Fluhr et al, 2001; Behne
et al, 2002). For example, permeability barrier recovery is
delayed when: (a) perturbed skin sites are exposed to neu-
tral pH buffers (Mauro et al, 1998) and (b) certain endog-
enous acidifying mechanisms are blocked or genetically
knocked out (Fluhr et al, 2001; Behne et al, 2002). Moreover,
short-term application of superbases, compounds that are
ten times more basic than in 1 N sodium hydroxide, delay
permeability barrier recovery following acute barrier disrup-
tion by tape stripping or acetone treatment, although basal
function remains normal (Hachem et al, 2003). The mech-
anism responsible for the barrier abnormality in these prior
examples involves the requirement of an acidic pH for
the maximal catalytic activity of certain lipid-processing en-
zymes, i.e., b-glucocerebrosidase (b-GlcCer’ase) (Vaccaro
et al, 1985; Hachem et al, 2003).
A third, potentially pH-mediated function is SC integrity,
defined as the resistance of the SC to mechanical tape
stripping, and a related parameter SC cohesion, defined as
the amount of protein removed per stripping (Fluhr et al,
2001; Hachem et al, 2003). Both parameters are altered by:
(a) short-term exposure of intact skin to neutral pH buffers
(Fluhr et al, 2001); (b) elevation of SC pH by blockade of an
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endogenous acidifying mechanism (Fluhr et al, 2001; Behne
et al, 2002); or (c) short-term applications of superbases
(Hachem et al, 2003). The compromise in SC integrity/co-
hesion was further shown to be attributable to accelerated
corneodesmosome (CD) degradation (Fluhr et al, 2001;
Hachem et al, 2003). The deleterious effects of an elevated
pH were further linked to high serine protease (SP) activity,
because co-applied serine protease inhibitors (SPI) normal-
ized both SC integrity/cohesion and CD degradation, even
in the face of an elevated pH (Hachem et al, 2003).
Because potentially confounding variables can occur
with either buffers, inhibitor treatment, or knockout animals
(i.e., hydration, non-specific toxicity, and unrelated, down-
stream effects, respectively), we recently developed a
method whereby SC pH could be experimentally altered,
independent of these variables (Hachem et al, 2003). In this
hairless mouse (Skh1/hr) model, short-term (3 h) neutrali-
zation of SC was achieved with a single, topical application
of a superbase. Whereas these studies demonstrated that
even brief elevations in SC pH alter barrier recovery kinetics
and SC integrity/cohesion, basal permeability barrier func-
tion remained unchanged (Hachem et al, 2003). Because a
sustained increase in SC pH is characteristic of most if not
all chronic inflammatory dermatoses (Chikakane and Taka-
hashi, 1995; Ohman and Vahlquist, 1998), we assessed here
whether more prolonged elevations in SC pH might provoke
profound functional abnormalities that could more closely
mimic these clinical situations. By repeatedly applying
the ‘‘superbase’’, 1,1,3,3-tetramethyl-guanidine (TMG), we
could sustain a neutral SC pH indefinitely without the de-
velopment of toxicity. Yet, maintenance of a neutral pH
was accompanied by profound abnormalities in both
basal barrier functions and SC integrity/cohesion that were
due to sustained SP activity, rather than just pH-induced
changes in enzyme catalytic activity. Indeed, such pro-
longed pH elevations lead to progressive degradation of
critical enzymes and structural proteins that mediate these
key functions.
Results
Neither toxicity nor inﬂammation results from pro-
longed sc neutralization Before assessing the conse-
quences of increased pH on epidermal function, we
measured SC pH after twice-daily application of TMG su-
perbase for 5–16 d. The surface pH of Skh1/hr skin, as-
sessed daily before TMG application, showed a sustained
and significant increase in SC pH in comparison with sites
treated with neutralized superbase (nTMG) or vehicle (Fig
1A). The increase in pH extended to all levels of the SC, and
it remained significantly higher, in TMG- than in nTMG-
treated sites (Fig 1B). Yet, despite the sustained elevations
in surface pH, there was no evidence of cutaneous abnor-
malities or inflammation in histologic sections, taken 5 or 16
d following TMG (or nTMG) treatment (Fig 2).
Sustained SC neutralization provokes abnormalities in
SC integrity/cohesion, attributable to sustained SP ac-
tivity After 5 d of repeated exposure of normal skin to
TMG, both SC integrity and cohesion deteriorated signifi-
cantly in comparison with the parameters in skin sites
treated with the nTMG (Figs 1C–E). SC integrity and cohe-
sion in nTMG-treated sites were comparable to vehicle-
treated and untreated skin (not shown). Co-applications
of SPI (soybean trypsin inhibitor (STI) or phenyl-
methanesulfonyl fluoride (PMSF)) blocked the deleterious
effects of the superbase on both SC integrity (Fig 1C and D)
and cohesion (Fig 1E). We next performed albuminþTMG-
treated controls to exclude whether the effects of SPI
co-application reflect non-specific mechanisms (e.g., ad-
sorption, protein–protein competition for access to sites of
SP activity, or partial neutralization of TMG). SC integrity
was assessed on TMG  0.5% albumin-treated sites and
compared with nTMG after 5 d of treatment (n¼ 8). No sig-
nificant differences in SC integrity (transepidermal water
loss (TEWL) measurements after three consecutive SC tape
stripping) were observed on albuminþTMG-treated flanks
(TEWL¼53.39  4.72 g per m2 per h) versus TMG alone
(TEWL¼50.16  4.83 g per m2 per h). Yet, TMG  albumin
still showed significant alterations in SC integrity in com-
parison with nTMGþ albumin (TEWL¼32.03  3.75 g per
m2 per h). Neither SPI alone, nor co-applications of SPI with
the superbase altered surface pH, i.e., the superbase in-
duced an increase in SC pH, even in the presence of an SPI.
Since two SP with known neutral pH optima, stratum
corneum chymotryptic enzyme (SCCE) and stratum corn-
eum tryptic enzyme (SCTE), regulate SC desquamation
through CD degradation (Egelrud and Lundstrom, 1991;
Backman et al, 1999; Johnson et al, 2003), we next as-
sessed SP activity in TMG  SPI (either STI or aprotinin)-
versus nTMG-treated skin sites by in situ zymography.
As shown in Fig 3, sustained SC neutralization enhanced
SP activity (Fig 3A), an increase that could be inhibited by
co-applications of either STI (Fig 3C) or aprotinin (not
shown). To assess the target SC protease activated by
sustained neutralization, in vitro zymography was per-
formed on SC extract from 5 d superbase-treated skin in
the presence of a panel of protease inhibitors, namely: (a)
pepstatin A (acidic protease inhibitor) and phenanthroline
monohydrate (metalloprotease inhibitor) or (b) pepstatin A,
phenanthroline monohydrate, and STI. Compared with
vehicle-treated skin, TMG application correlates with a sig-
nificant increase in SP activity of SC extracts even in the
presence of pepstatin A and phenanthroline monohydrate
(Fig 3D and E). Yet, addition of STI overrides TMG-induced
proteolysis (Fig 3D and E). Together, these results show that
a prolonged SC neutralization results in deterioration of SC
integrity and cohesion and, that these functional changes
are due to an increase in SP activity.
Sustained SC neutralization accelerates SP-mediated
degradation of CD We next assessed the structural and
biochemical basis for the abnormalities in SC integrity and
cohesion that result from sustained SC neutralization.
Twice-daily applications of TMG for 5 d again raised SC
pH, accompanied by a significant decrease in the density of
CD in the lower SC, extending even to the stratum gran-
ulosum (SG) interface, assessed by quantitative electron
microscopy. These effects were more pronounced than
previously observed with short-term (3h) SC neutralization
(Fig 4, see also Hachem et al, 2003). Not only the density of
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CD but also the size of individual junctions in the lowermost
SC layer was markedly reduced (Fig 4A–C). In contrast, re-
peated nTMG applications altered neither CD density (Fig
4A–C) nor the size of CD in comparison to either vehicle-
treated or untreated SC (Fig 4A–C; untreated data not
shown). The decrease in CD could be further ascribed to
a superbase-induced increase in SP activity (see above
zymography results), because co-applications of STI, along
with TMG, prevented the decrease in CD density and size
(Fig 4A–D). Finally, we assessed whether the superbase-
induced decrease in CD density was attributable to loss of
its constituent proteins, assessed as desmoglein 1 (DSG1)
content in western blots of SC from TMG  STI- and nTMG-
treated SC. DSG1 immunoblotting indicated extensive pro-
teolysis of DSG1 after 5 d of sustained neutralization of
normal SC, a change that was again blocked by co-appli-
cations of STI (Fig 4E–F). In addition, DSG1 proteolysis
again was more marked after 5 d of SC neutralization than
occurred with 3 h of acute alkalization (Fig 4F, see also
Hachem et al, 2003). Together, these results show that the
decline in SC integrity and cohesion from prolonged SC
neutralization can be ascribed to sustained SP activity,
leading to progressive degradation of CD and its constituent
proteins.
Figure 1
Repeated applications of superbase result in sustained stratum corneum (SC) neutralization and alterations in SC integrity/cohesion. (A)
Topical application of tetra-methyl-guanidine (TMG: 6.5/100; vol/vol in propylene glycol:ethanol) induces sustainable neutralization of SC pH over 5 d
in comparison with neutralized tetra-methyl-guanidine (nTMG). (B) At day 5 after TMG applications, sequential tape strippings show that the increase
in pH is sustained, remaining significantly different at all levels of SC. (C–E) SC integrity and cohesion decline after 5 d of TMG (6.5:1000 vol/vol in
propylene glycol ethanol 7:3) but not nTMG treatment. Co-applications of either soybean trypsin inhibitor (STI, 0.5%) or phenylmethanesulfonyl
fluoride (10 mM) prevent these alterations. Results shown are the mean  SD (n¼4–6).
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Sustained elevations in SC pH not only delay barrier
recovery but also increase basal TEWL Although our
prior studies showed that a short-term increase in SC pH
does not alter basal barrier function (Hachem et al, 2003),
the sustained elevation in SC pH induced by repeated su-
perbase applications produced a more profound barrier
abnormality indicated by increased basal TEWL levels
(4.75  0.52 g per m2 per h vs 1.62  0.04 g per m2 per h
on TMG- vs nTMG-treated sites, po0.01) without affecting
the level of SC hydration (55.19  1.50 vs 56.38  1.48 on
TMG vs nTMG-treated sites, in relative units). The super-
base-induced abnormality in basal TEWL was again pre-
vented by co-applications of STI (1.7  0.12 g per m2 per h).
To determine whether sustained SC neutralization also al-
ters the kinetics of barrier recovery, we next compared bar-
rier recovery after repeated tape stripping (TEWL46–8 g
per m2 per h) of flanks treated for extended periods with
either TMG or nTMG  STI. As shown in Figure 5, super-
base (TMG)-treated sites exhibited a marked delay in barrier
recovery in comparison with control (nTMG)-treated sides.
Finally, SC hydration levels remained unchanged in all treat-
ment groups, indicating that SC neutralization does not
affect SC hydration. These results show that sustained
neutralization of SC alters both basal barrier function, and
the kinetics of barrier recovery.
Abnormal lipid processing accounts for the barrier ab-
normality To assess the structural basis for the sustained
superbase-induced abnormalities in permeability barrier
homeostasis, we next compared SC extracellular lamellar
membrane structures in TMG- and control (nTMG)-treated
skin, with or without a co-applied SPI. Under basal condi-
tions, prolonged SC neutralization resulted in striking struc-
tural defects, i.e., delayed membrane maturation in the
extracellular domains of the lower SC (Fig 6). In contrast,
membrane structures were normal in sites treated repeat-
edly with nTMG, and in sites treated with SPIþTMG (Fig 6).
Together, these results show that sustained SC neutraliza-
tion results in abnormal lipid processing, linked to pro-
longed SP activity, which, in turn, explains the abnormalities
in permeability barrier homeostasis.
Abnormal lipid processing from sustained neutraliza-
tion is attributable to degradation of lipid-processing
enzymes To further explore the mechanisms that account
for both abnormal barrier homeostasis and impaired lipid
processing, we next assessed the in situ activity of two key
lipid-processing enzymes with known acidic pH optima
(Vaccaro et al, 1985; He et al, 1999); b-GlcCer’ase and
acidic sphingomyelinase (aSMase). Enzyme activity was
assessed in TMG- and nTMG  SPI (aprotinin or STI)-treat-
ed skin sites by in situ zymography. Both b-GlcCer’ase and
aSMase activities decreased markedly in skin sites that
were neutralized for 5 d (Figs 7A–E and 8). To ascertain
whether the decreased activity reflects changes in enzyme
catalytic activity alone, as occurred with acute pH increase
(Hachem et al, 2003), we next assessed whether enzyme
activities were normalized by re-acidification. In contrast
to acute elevations in SC pH, where enzyme activity can
be restored by re-acidification (Hachem et al, 2003), b-
GlcCer’ase and aSMase activity did not recover when sites
that were neutralized for several days were re-acidified (Figs
7C and 8C). Yet, despite a sustained neutral pH, SPI co-
applications completely reversed the TMG-induced chang-
es in b-GlcCer’ase and aSMase activity, but only when
sections from TMGþSTI-treated skin were also re-acidified
(Figs 7D and 8D). Since these results suggest that SP-me-
diated enzyme degradation could be occurring, with pro-
longed neutralization, we next assessed enzyme content by
both immunohistochemistry and western immunoblotting.
Both immunostaining (Fig 7F–H) and immunoblotting (Fig
9A) for b-GlcCer’ase and immunoblotting (Fig 9B) for aS-
Mase showed a decline in enzyme mass subsequent to
prolonged neutralization of SC. Here again, co-application
of SPI reversed the observed decrease of processing en-
zyme mass (Figs 7–9). Since SCCE is believed to be a cen-
tral target activated by the prolonged elevation of SC pH,
we analyzed whether b-GlcCer’ase and aSMase proteins
are substrates for these proteases in vitro. Protein extracts
from human SC were therefore treated for 2 h at 371C with
SCCE at pH 7.2, and the incubated extracts were analyzed
by immunoblotting with either anti-b-GlcCer’ase or anti-aS-
Mase antibodies (Fig 10). Recombinant SCCE induced a
decrease in the immunoblotting of both b-GlcCer’ase or
aSMase compared with control experiments performed in
the absence of the active SCCE (Fig 10). These results fur-
ther demonstrate that proteolytic degradation of both b-
GlcCer’ase aSMase occurs with a sustained increase in SC
pH, and show that SCCE produces a catalyzed proteolysis
of key lipid processing secondarily responsible for the ob-
served permeability barrier abnormalities.
Figure 2
A sustained increase in pH does not alter skin histology. Hem-
atoxylin- & eosin-stained paraffin sections 5 d after either 1,1,3,3-tetra-
methyl-guanidine (TMG) (6:1000 vol/vol in propylene glycol ethanol 7:3)
(A), neutralized tetra-methyl-guanidine (nTMG) (B), or no treatment (C)
of hairless mice show no changes in cellular or epithelial structures, or
evidence of dermal inflammation, with repeated superbase applica-
tions. Scale bar¼10 mm.
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Discussion
Previous studies have demonstrated that acute transient
increases in SC pH induce abnormalities in the recovery of
permeability barrier function after acute barrier disruption
without inducing abnormalities in basal TEWL (Hachem
et al, 2003). This abnormality in permeability barrier home-
ostasis was due to impaired extracellular lipid processing in
the SC, indicated by the presence of immature lamellar
membranes in the SC. The pH-induced processing defect
could be further attributed to decreased catalytic activity,
but not enzyme mass, of a key lipid-processing enzyme
with acidic pH optima, b-GlcCer’ase (Hachem et al, 2003).
In addition, transient neutralization of SC also induced ab-
normalities in SC integrity and cohesion that were linked to
increased SP-mediated degradation of CD.
Whereas the abnormalities induced by such transient in-
creases in SC pH are significant, they may not be of great
clinical relevance. Inflammatory dermatoses, such as pso-
riasis, atopic dermatitis, and seborrheic dermatitis, demon-
strate an in SC pH that parallels disease activity (Beare et al,
1959; Jolly, 1960; Yosipovitch et al, 1993). Moreover, the
increase in pH in these disorders is paralleled by increased
SP activity (Murahata et al, 1988; Chikakane and Takahashi,
1995). Hence, we asked here whether more substantial ab-
normalities would emerge if a neutral SC pH could be sus-
tained experimentally for longer time periods and whether a
high SP activity is critical for these abnormalities. Indeed,
our results demonstrate that sustained pH alterations pro-
duce more profound abnormalities in permeability barrier
function and SC integrity/cohesion. These are found with
transient elevations. The more profound nature of the func-
tional abnormalities is shown by the elevations in basal
TEWL induced by the sustained increase in SC pH. Like-
wise, the SC integrity abnormality is more profound, with a
further degradation of CD, extending even to the SG–SC
interface.
Since sustained increases in SC pH produced alterations
that were even more profound than those produced by
transient pH increase, intrinsic homeostatic mechanisms
were not sufficiently upregulated to correct the pH-induced
functional disturbances, which are assessed here, i.e., bar-
rier function and SC integrity/cohesion. Yet, it is important to
note that toxicity or inflammation did not emerge, suggest-
ing that some or yet undetermined responses protect the
skin from inflammation (Hachem et al, 2002). The lack of a
sufficient homeostatic response to pH contrasts with the
effects produced by alterations in humidity, which progres-
sively modify epidermal barrier function to a level appropri-
ate for the environmental insult (Denda et al, 1998).
Figure 3
Sustainable stratum corneum (SC) neutralization induces increased serine protease (SP) activity, inhibited by soybean trypsin inhibitor
(STI). (A–C) In situ zymography 5 d after repeated superbase treatments shows an increase in SP activity in TMG (6.5:1000 vol/vol in propylene
glycol ethanol 7:3) (A and D) versus neutralized 1,1,3,3-tetra-methyl-guanidine (nTMG) (B and E)-treated sites. Co-application of either STI (0.5%) (C)
with TMG inhibits pH-induced SP activity. Scale bar¼ 10 mm. (D, E) In vitro zymography performed on SC extracts 5 d after repeated superbase
treatments shows a TMG-induced increase in protease activity in the presence of pepstatin A and phenanthroline monohydrate [TMGþ (a)]
compared with vehicle treatment [nTMGþ (a)]. Unlike acidic and metallo-protease inhibitors, addition of STI [TMGþ (b)], a serine protease inhibitor,
to the reaction substrate downregulated TMG-induced proteolysis. Results shown in E are the mean of the areas under the curve (AUC)  SD
calculated from the data in D. The latter are measured as emitted fluorescence at an excitation/emission wavelength of 485/530 per mg sample
protein (n¼4–6).
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Two SC SP with a convincing link to desquamation have
been described to be present in the SC: SCCE and SCTE
(Caubet et al, 2004). Yet, SCCE, which is found in both hu-
man and murine SC (Hansson et al, 1994; Backman et al,
1999), has been shown to be implicated in pro-inflammatory
epidermal responses (Nylander-Lundqvist and Egelrud,
1997) and may contribute to disease pathogenesis and/or
maintenance (Ekholm and Egelrud, 1999; Hansson et al,
2002; Ny and Egelrud, 2004). Hence, all of the pH-induced
abnormalities in SC function can be further linked to
enhanced SP activity, because inhibition of SP activity
blocked the abnormalities in both SC integrity/cohesion and
permeability barrier homeostasis. Although increased SP
activity accounted for all of these functional changes, dif-
ferent downstream mechanisms were responsible for each
functional abnormality. In the case of the abnormalities in
SC integrity/cohesion, increased SP activity leads to accel-
erated degradation of DSG1, a structural protein required
for CD formation, resulting in degradation of CD, which ac-
counts for decreased SC integrity/cohesion, as with tran-
sient pH increase (Hachem et al, 2003), but more global in
case of sustained pH elevations. As for permeability barrier
homeostasis, increased SP activity leads to degradation of
both b-GlcCer’ase and aSMase, enzymes that are essential
for the extracellular lipid processing required for normal
permeability barrier homeostasis (Holleran et al, 1994; Jen-
sen et al, 1999).
Although we have demonstrated that the degradation of
key structural and enzymatic SC proteins is accelerated by
the increase in SP activity that results from an increased SC
pH, it is possible that other, as yet unidentified SC proteins
Figure 4
Corneodesmosome (CD) density declines after sustained stratum corneum (SC) neutralization paralleled by serine protease-dependent
degradation of desmoglein I (DSG1). (A–C) 1,1,3,3-tetra-methyl-guanidine (TMG)-treated skin (6.5:1000 vol/vol in propylene glycol ethanol 7:3)
shows a progressive decrease in CD density and length (A) in comparison with neutralized TMG (nTMG) treatment (B). Co-applications of soybean
trypsin inhibitor (STI, 0.5%) with TMG prevent the superbase-induced loss of CD (C). Scale bars¼0.25 mm. (D) Quantitative electron microscopy
analysis shows a significant decrease in CD density after 5 consecutive days of TMG applications in the lower SC, between the first (SC1) and the
second (SC2), extending even to the stratum granulosum interface (SG/SC1). Compared with 3 h neutralization, the CD density is significantly more
pronounced at the SG1/SC1 in the long-term neutralization model (5 d). CD density is normalized in superbase-treated skin by co-applications of STI
(0.5%) with TMG (6.5:1000 vol/vol in propylene glycol ethanol 7:3). Results shown are the means  SD (n¼ 30 micrographs in each experimental
group). (E, F) Protein extracts from SC were loaded onto Tris-glycine PAGE gels, and after transfer onto a nitrocellulose membrane, incubated further
with DSG1 antibody at 41C overnight. Blot E shows a decrease in DSG1 immunostaining on TMG-treated (4–5) versus nTMG (1–3) or TMGþSTI-
treated sites (7–9). Blot F shows a relative decrease in DSG1 immunostaining with long-term (5 d; 3 and 4) TMG application sites compared with
short-term application (3 h; 1 and 2)
Figure 5
Barrier recovery normalizes when superbase-treated skin is co-
treated with serine protease inhibitor (SPI). Transepidermal water
loss was measured prior and following acute barrier disruption by re-
peated cellophane tape stripping at the end of 5 d of treatment, using
an electrolytic water analyzer (MEECO). Barrier recovery kinetics (ex-
pressed in % of barrier recovery) assessed 3 h after acute disruption is
delayed as a result of sustainable SC neutralization with twice-daily
applications of 1,1,3,3-tetra-methyl-guanidine (TMG) versus neutralzed
TMG (nTMG). The TMG-induced delay is reversed by the co-applica-
tion of SPI ( soybean trypsin inhibitor and phenylmethanesulfonyl flu-
oride). Results shown are mean  SD (n¼ 4 in each group).
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could also be degraded, which could have adverse effects
on crucial SC functions. Thus, stimulation of SP activity by
prolonged increases in SC pH could provoke effects in ad-
dition to those described in this study. Finally, it should be
recognized that some of these pH-induced effects could
occur independent of increased SP activity. It is possible
that an increased SC pH could alter the activity of one or
more of these additional enzymes, independent of SP ac-
tivation, thereby altering SC function, as we have shown for
b-GlcCer’ase and aSMase, whose catalytic activities were
changed with pH alterations alone.
Sustained elevations in SC pH are an appropriate model
for neonatal skin, which displays normal basal barrier func-
tion, but abnormalities in both barrier recovery and SC
integrity/cohesion. In addition, the sustainable increase in
SC pH may be a model for occupational diseases, such as
irritant or allergic contact dermatitis, with prolonged contact
with alkaline substances. Whereas contact dermatitis is
aggregated when the allergen or irritant is applied at an
elevated pH (Murahata et al, 1988), it is well recognized that
alkaline detergent-induced cutaneous disorders are char-
acterized by an increased SC pH (Baranda et al, 2002) and
display disturbances in permeability barrier function (Hac-
hem et al, 2002). It is possible that the sustained increase in
SC pH in these cutaneous disorders further aggravates and
sustains abnormalities in SC function that, in turn, could
further worsen barrier abnormalities (a positive cycle of
worsening disease leading to increased SC pH leading to
worsening of disease), and/or make the occupational de-
rmatoses more resistant to therapy.
In summary, this study demonstrates that sustained in-
creases in SC pH, by stimulating SP activity, adversely af-
fect a range of SC functions, including a decrease in SC
integrity/cohesion, impaired permeability function, and the
related mechanisms to these aberrations.
Materials and Methods
Materials Male Skh1/Hr, 6–8-wk old, were purchased form
Charles River Laboratories (Wilmington, Massachsetts) and fed
Purina mouse diet and water ad libitum. Propylene glycol, ethanol,
and HCl were from Fisher Scientific (Fairlane, New Jersey), where-
as TMG, STI, aprotinin PMSF, pepstatin A, and phenanthroline
monohydrate were from Sigma Chemicals (St Louis, Missouri).
Rabbit antibodies against mouse DSG1 and b-GlcCer’ase were
gifts from Dr John Stanley (University of Pennsylvania) and Dr Ellen
Sidransky (National Institutes of Mental Health, Bethesda), respec-
tively. Anti-aSMase antibody (mouse, rat, and human specific) was
purchased from Santa Cruz Biotechnology (Santa Cruz, California).
Goat anti-rabbit Alexa-labeled secondary antibodies were pur-
chased from Molecular Probes (Eugene, Oregon). Horseradish
peroxidase-conjugated, anti-rabbit IgG was purchased from Vec-
tor Labs (Burlingame, California). The active form of the human
SCCE was a generous gift from Arexis AB (Go¨teborg, Sweden).
The EnzChek Protease Assay Kit containing BODIPY-FL-Casein
(green fluorescence), resorufin a–D-glucopyranoside, and Amplex
Red reagent was purchased from Molecular Probes, and used for
in situ zymography (see below). In all, 22 mm D-Squame-100 tapes
were purchased from CuDerm (Dallas, Texas). Bradford protein
assay kits (Bio-Rad Protein Assay Dye), as well as lyophilized, bo-
vine plasma g-globulin were purchased from Bio-Rad (Hercules,
California).
All procedures were performed while mice were anesthetized
with chloral hydrate (Morton Grove Pharmaceuticals, Morton
Grove, Illinois), under a protocol approved by the VA Animal Care
Committee.
SC neutralization
Maintenance of SC neutralization Normal Skh1/hr were treated
topically with twice-daily applications of TMG (6,5/1000, vol/vol;
pH¼ 12.8) in propylene glycol:ethanol (7:3 vol/vol; pH¼ 7.0) at 12 h
intervals for 5–16 d on a 5–6 cm2 area on each flank. Because
superbases and superacids are, by definition, at least 10 order of
magnitude more basic or more acidic than 1 N sodium hydroxyde
(NaOH) and 1 N sulfuric acid, respectively (Oyama and Kondo,
2003), they can be used to manipulate pH locally at very low con-
centrations (Hachem et al, 2003). In addition, their lipophilic naph-
thalene structure favors absorption throughout the SC, so that the
pH elevation extends to deeper SC layers (Hachem et al, 2003).
Control Skh1/hr were treated similarly with HCl-neutralized TMG
(nTMG) in propylene glycol:ethanol (7:3 vol/vol), or with vehicle
alone (same concentrations and volumes).
For the SPI experiments, animals received co-applications of
0.5% STI, or PMSF 0.5% aprotinin coincidentally with TMG or
nTMG treatments. Co-applied SPI did not alter the pH of the ap-
plied solutions. In another set of experiments, albumin (5 mg per
mL) was co-applied with TMG in order to exclude non-specific
mechanisms that could inhibit protease activity such as adsorption
or protein–protein competition for access to sites of SP activity.
Figure 6
Superbase-induced lipid processing abnormality is reversed by a
co-applied serine protease inhibitor (SPI). (A) Daily application of the
superbase 1,1,3,3-tetra-methyl-guanidine (TMG), results in the persist-
ence of unprocessed (immature) lamellar membranes (open arrows)
above the stratum granulosum (SG)–stratum corneum (SC) interface.
(B) Sites treated similarly with the neutralized superbase (nTMG) reveal
mostly processed lamellar membranes (solid arrows) within the inter-
cellular domains between the first (SC1) and second (SC2) cornified
layers. (C) Co-applications of a soybean trypsin inhibitor (SPI) with the
superbase reveal normal membrane processing (solid arrows) at all
levels of the SC. Scale bars¼ 0.25 mm. (A–C), RuO4 post-fixation.
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Acute neutralization model Normal Skh1/hr were treated topically
with a single application of either TMG (1:100; vol/vol) in propylene
glycol: ethanol (7:3 vol/vol) on 5–6 cm2 areas on both flanks as
described previously (Hachem et al, 2003). Controls were treated
with HCl-neutralized TMG (nTMG) in propylene glycol:ethanol (7:3
vol/vol).
Assessment of epidermal function
SC pH Surface pH was measured with a flat, glass surface-elec-
trode from Mettler-Toledo (Giessen, Germany), attached to a pH
meter (Skin pH Meter pH Model 900; Courage & Khazaka, Co-
logne, Germany). Evaluation of skin surface pH was performed
once daily immediately prior to treatment with either TMG, nTMG,
or vehicle.
Permeability barrier function To assess epidermal permeability
function, TEWL was measured daily immediately prior to the next
application of TMG  STI or nTMG. TEWL was measured both
under basal conditions, as well as following acute barrier disruption
by repeated cellophane tape stripping at the end of five days of
treatment, using an electrolytic water analyzer (MEECO; Warring-
ton, Pennsylvania). Barrier recovery kinetics were then assessed
3 h after acute disruption.
SC hydration SC hydration was determined by electrical capac-
itance, measured in arbitrary units with a Corneometer CM Model
810 (Courage & Khazaka), before and 5 d after applications of
TMG  STI, nTMG, or vehicle.
SC integrity Before stripping experiments, the skin surface was
cleaned with a single ethanol wipe. D-Squame tapes then were
placed sequentially onto the test areas for about 3 s each, removed
with forceps, and stored at 41C in glass scintillation vials. Sequen-
Figure 7
Defective barrier homeostasis from sustainable neutralization is attributable to both downregulation and degradation of a key lipid-
processing enzyme b-glucocerebrosidase (b-GlcCer’ase). b-GlcCer’ase in situ zymography shows decrease in enzyme activity on sections from
skin sites treated for 5 d with 1,1,3,3-tetra-methyl-guanidine  serine protease inhibitor, namely soybean trypsin inhibitor (STI) versus neutralized
TMG (nTMG) (A). b-GlcCer’ase enzyme activity is reversed by acidification of TMGþSTI co-treated, but not with reacidification of sites treated with
TMG alone (C vs E). These results suggest both a pH-dependent, downregulation of enzyme activity, and a protease-dependent degradation of b-
GlcCer’ase enzyme with sustained superbase treatment. Similarly, immunostaining for b-GlcCer’ase decreased with SC neutralization by TMG (G),
but not in parallel, nTMG-treated sites (F), nor in sites co-treated with STI (H).
Figure 8
Defective barrier homeostasis from sustainable neutralization is
attributable to both downregulation and degradation of a key lipid-
processing enzyme acidic sphingomyelinase (aSMase). aSMase
in situ zymography shows decrease in enzyme activity on sections
from skin sites treated for 5 d with 1,1,3,3-tetra-methyl-guanidine
(TMG)  serine protease inhibitor (B), namely Aprotinin (C) versus neu-
tralized TMG (nTMG) (A). C and D show a small enzyme activity band in
the stratum corneum compared with A. aSMase enzyme activity is
reversed by acidification of TMGþ aprotinin co-treated (E), but not with
re-acidification of sites treated with TMG alone (D). These results sug-
gest a pH-dependent downregulation and degradation of aSMase with
sustained superbase treatment.
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tial tape strippings were performed on the flanks of Skh1/hr 12 h
after the last application of TMG  STI or nTMG. TEWL was eval-
uated before and after each tape strip, and the rate of change in
TEWL equated to SC integrity.
SC cohesion The amount of protein removed per D-Squame strip
was measured as previously described (Dreher et al, 1998). This
microassay system has been shown to be linear in the range of
1–10 mg per mL, using human SC removed from a heel callus as
the protein source (calculated slope Rf¼ 0.0297  0.0006; Spear-
man coefficient: 0.999; po0.0001). The protein content per strip-
ping was determined with the Bio-Rad Protein Assay Kit.
Lyophilized, bovine gamma globulin was used as the standard in
all assays, because it correlated best with human SC. Each tape
was incubated with 1 mL of 1 M NaOH for 1 h at 371C in an
incubator shaker at 80 rpm, and neutralized thereafter with 1 mL of
1 M HCl in the scintillation vials. Subsequently, 0.2 mL of this so-
lution was incubated in 0.6 mL distilled water plus 0.2 mL of the
Bio-Rad protein dye for 5 min in borosilicate tubes. After incubat-
ions, the reagents were transferred to polysterene cuvettes, and
absorption was measured with a Genesys 5 spectrophotometer
(Spectronic, Rochester, New York) at 595 nm. An empty D-Squame
tape, as well as distilled water incubated with the Bio-Rad dye,
served as negative controls. The amount of calculated protein was
then normalized to the skin surface area (mg per cm2). The amount
of removed protein per D-Squame strip agreed with previous re-
ports of SC from untreated skin of Skh1/hr (i.e., range 2.5–4 mg per
strip) (Dreher et al, 1998; Fluhr et al, 2001).
Zymography assays
SP
(a) In situ: Skh1/hr flanks were excised from treated animals, and
the subcutaneous fat was removed. Frozen sections (8 mm)
were rinsed with a washing solution (1% Tween 20 in deionized
water) and incubated at 371C for 2 h with 250 mL of BODIPY-Fl-
casein (1 mg per mL) in deionized water (2 mL per mL). The
acidification-reversal experiments utilized the same fluoroph-
ores in 10 mM morpholino-ethanesulfonic (MES) acid, sodium
buffer (pH 5.5) as the in situ incubation medium, again at 371C
for 2 h. All sections were then rinsed with the 1% Tween 20
washing solution, coverslipped, and visualized under a confo-
cal microscope (Leica TCS SP, Heidelberg, Germany) at an ex-
citation wavelength of 485 nm and an emission wavelength of
530 nm.
(b) In vitro: SC was isolated from treated Skh1/hr flanks using se-
quential D-Squame tape strippings until the glistening layer
(¼ 1 remaining SC layer by EM) was reached. Hematoxylin and
eosin staining was performed on paraffin sections from por-
tions of all tape-stripped areas to insure equivalent depth of SC
removal in all experiments. D-squame tapes were then incu-
bated overnight at 41C in 1% Triton X-100 in deionized water,
and then sonicated for 5 min on ice to extract proteins from the
tapes. 100 mL of extracted SC, in three duplicates from each
treatment (n¼ 4), was incubated at 371C with 100 mL BODIPY-
Fl-casein (1 mg per mL) for 300 min in a microplate reader (Per-
kin-Elmer 1420 VICTOR multilabel plate reader, BE Perkin-
Elmer, Brussels, Belgium) in the presence of either (i) pepstatin
(acidic protease inhibitor, 2 mg per mL) and phenanthroline
monohydrate (metalloprotease inhibitor, 1 mM) or (ii) pepstatin
(2 mg per mL), phenanthroline monohydrate (1 mM) and STI
(0.1% vol/vol). Fluorescence was monitored every 10 min at
an excitation/emission wavelength of 485/530, and protease
activity was determined as measured fluorescence per mg
protein present in each sample.
b-GlcCer’ase Skh1/hr flanks were excised and sectioned as
above. Frozen sections were washed with the 1% Tween 20
washing solution and incubated at 371C for 2 h with 250 mL of 1
mM resorufin a-D-glucopyranoside in deionized water (Hachem
et al, 2003). The acidification-reversal experiments were performed
in 10 mM MES buffer (pH 5.5), as above. All sections were then
rinsed with the washing solution, coverslipped, and visualized un-
der the confocal microscope at an excitation wavelength of 588 nm
and an emission wavelength of 644 nm.
aSMase Skh1/hr flanks were excised and sectioned as above.
Frozen sections were washed with the 1% Tween 20 washing so-
lution and incubated at 371C for 2 h with 250 mL of 100 mM Amplex
Red reagent (containing 2 U per mL HRP, 0.2 U per mL choline
oxidase, 8 U per mL of alkaline phosphatase) in deionized water. All
sections were then rinsed with the washing solution, coverslipped,
and visualized under the confocal microscope at an excitation
wavelength of 588 nm and an emission wavelength of 644 nm.
Immunoﬂuorescence Skh1/hr skin was excised from treated an-
imals, and the subcutaneous fat was removed. Paraffin tissue sec-
tions from TMG  SPI or nTMG treated mice were incubated for
30 min in blocking buffer (1% bovine serum albumin, 0.1% cold-
water fish gelatin in phosphate-buffered saline (PBS)) and were
then incubated for 24 h at room temperature with 1:100 dilution of a
primary antibody against rabbit b-GlcCer’ase, diluted in blocking
Figure 9
Sustainable stratum corneum (SC) neutralization induces a serine
protease-dependent degradation of b-glucocerebrosidase (b-
GlcCer’ase) and acidic sphingomyelinase (aSMase). Protein ex-
tracts (n¼ 2 each) from whole epidermis for and SC for aSMase and
loaded onto Tris-glycine PAGE gels, and after transfer onto a nitrocel-
lulose membrane, incubated further with either aSMase or b-GlcCer’-
ase antibody at 41C overnight. Blots show a decrease in both b-
GlcCer’ase and aSMase immunostaining on 1,1,3,3-tetra-methyl-
guanidine (TMG)-treated (5–6) versus neutralized TMG (nTMG) (3 and
4) or TMGþaprotinin (1 and 2)-treated sites.
Figure 10
Stratum corneum (SC) chymotryptic enzyme induces proteolysis
of b-glucocerebrosidase (b-GlcCer’ase) and acidic sphingomyeli-
nase (aSMase) at pH 7.2. To evaluate the importance of stratum
corneum chymotryptic enzyme (SCCE) in the degradation of b-
GlcCer’ase and aSMase, SC protein extracts from six healthy individ-
uals were pooled into two samples and incubated at 371C in the pres-
ence (1–2 and 5–6) or absence (3–4 and 7–8) of recombinant active
SCCE for 2 h at pH¼7.2. The incubated extracts were analyzed by
immunoblotting with either anti-b-GlcCer’ase or anti-aSMase antibod-
ies. A significant decrease in the immunostaining for both enzymes (1–2
and 5–6) is observed 2 h following incubation with SCCE.
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buffer. The tissue sections were then washed with PBS, and incu-
bated for 1 h at room temperature with the goat anti-rabbit anti-
body, diluted in blocking buffer. Tissue sections were then washed
with PBS, and mounted before visualization under a confocal micro-
scope (Leica TCS SP, Heidelberg, Germany) at an excitation wave-
length of 488 nm and an emission wavelength of 518 nm.
Western immunoblotting For DSG1 and aSMase, SC was iso-
lated from treated Skh1/hr flanks using sequential D-Squame tape
strippings as described above (cfr Zymography assay; SP, in vitro),
except that the overnight incubation at 41C was performed in the
presence of 1% Triton X-100 and a protease inhibitor cocktail
(Complete Mini, EDTA-Free, Hoffmans La Roche, 1 tablet per 10
mL Hoffmans LaRoche, Brussels Belgium) in deionized water. For
b-GlcCer’ase, whole epidermis was isolated from treated flanks
using the heat split technique (Allen et al, 1997). Briefly, after ex-
cision, skin flanks were placed dermis side downward in Petri
dishes and exposed to heat (601C). After 60 s, the epidermis was
gently scraped off the dermis, and proteins were extracted by
sonication (15 s, three times) in extraction buffer (Tris base 62 mM,
2% SDS containing a protease inhibitor cocktail). The protein con-
tent of tape stripping or epidermis extracts was then determined,
as above. Equal amounts of protein from each experimental group
were loaded onto 4%–12% Tris-glycine polyacrylamide gels
(PAGEr Gold Precast Gels, BioWhittaker Molecular Applications,
Rockland, Maine). After electrophoresis, proteins were transferred
from the slab gel onto nitrocellulose membranes and immunoblot-
ted to detect DSG1, b-GlcCer’ase, or aSMase, using the Western
Lightening chemiluminescence kit (Perkin-Elmer Life Sciences,
Boston, Massachusetts).
SCCE proteolysis experiments Proteolysis experiments were
performed on SC extracts as described previously (Caubet et al.
2004) with the following modifications. Briefly, human SC was iso-
lated from the heel of six healthy individuals (mean age  SD
25  5.3 y old), and proteins were extracted in PBS buffer
(pH¼ 7.2, 1% Triton-X 100) at 41C overnight. SC extracts from
each three individuals were pooled into two separate samples and
the protein content was then determined, as above. 50 mg of each
sample was incubated in the presence or absence of 100 ng re-
combinant active SCCE for 2 h at 371C. Reactions were stopped
by boiling for 2 min in sample buffer. Samples were separated by
SDS-PAGE and analyzed by immunoblotting for b-GlcCer’ase and
aSMase as described above.
Light and electron microscopy (EM) Skin biopsy samples were
taken 5 d after the initiation of TMG  STI or nTMG treatments
(n¼ 3 from each group) and processed for light and EM. Samples
were minced too0.5 mm3, fixed in modified Karnovsky’s fixative
overnight, and post-fixed in either 0.2% ruthenium tetroxide
(RuO4), or 1% aqueous osmium tetroxide (OsO4), containing
1.5% potassium ferrocyanide, as described previously (Hou et al,
1998). After fixation, all samples were dehydrated in graded et-
hanol solutions, and embedded in an Epon–epoxy mixture. Ultra-
thin sections were examined, with or without further contrasting
with lead citrate, in an electron microscope (Zeiss 10A; Carl Zeiss,
Thornwood, New York) operated at 60 kV.
Statistical analyses and CD EM quantiﬁcation Statistical anal-
yses were performed using Prism 2 (GraphPad Software, San Di-
ego, California). Two groups were compared with a Student’s t test.
In order to quantify CD density by EM, ten pictures of the outer
epidermis were taken at random from each sample at 31.5K mag-
nification. The ratio between the total lengths of all CD to the total
length of cornified envelopes at the SG/SC junction, as well as
surrounding the first SC cell layer, was determined using a plani-
meter. Non-parametric Mann–Whitney statistical analyses were
performed to compare percent ratios between different groups of
treatments (Morris 2000).
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